SCHEMBL4140684

SCHEMBL4140684

COc1ccc(COc2ccnc(C)c2OCc2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.53
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
BCHE P06276 5/20 0.46
LTA4H P09960 1/20 0.46
HTR1A P08908 1/20 0.45
ADRA1D P25100 1/20 0.45
ADRA1A P35348 1/20 0.45
ADRA1B P35368 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
MAOB P27338 1/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PRMT5 O14744 1/20 0.44
MAOA P21397 1/20 0.43
LMNA P02545 2/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4898749 0.90 L3MBTL1 (0.53) ABCB1LTA4HHTR1AADRA1DADRA1A
SCHEMBL5583648 0.87 BCHE (0.50) BCHEHTR1AADRA1DADRA1AADRA1B
SCHEMBL4688192 0.87 L3MBTL1 (0.50) ABCB1LTA4HHTR1AADRA1DADRA1A
SCHEMBL4159575 0.84 ABCB1 (0.51) ABCB1NPC1RAB9ABCHELTA4H
SCHEMBL4157654 0.82 ABCB1 (0.49) ABCB1NPC1RAB9ABCHELTA4H
SCHEMBL4152950 0.82 RAB9A (0.50) ABCB1NPC1RAB9AHTR1AADRA1D
SCHEMBL16740415 0.78 MAOA (0.39) BCHELTA4HHTR1AADRA1DADRA1A
SCHEMBL31530947 0.78 NPC1 (0.51) ABCB1NPC1RAB9AMAOBTDP1
SCHEMBL4153190 0.78 ALDH1A1 (0.47) ABCB1NPC1RAB9AMAOBALDH1A1
SCHEMBL12301192 0.78 NPC1 (0.70) ABCB1NPC1RAB9ALTA4HHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099168-A1 HIV Integrase inhibitors DONGHI MONICA 2009-04-16 US disclosed
US-20070161639-A1 Hiv integrase inhibitors ISTITUTO DI RICHERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-07-12 US disclosed
EP-1725554-A1 HIV INTEGRASE INHIBITORS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2006-11-29 EP disclosed
WO-2005087766-A1 HIV INTEGRASE INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2005-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161639-A1 Hiv integrase inhibitors DPYD, DUT, TYMP ABCB1 975/4885NPC1 4324/4885RAB9A 1733/4885
US-20090099168-A1 HIV Integrase inhibitors DPYD, DUT, QDPR ABCB1 918/4885NPC1 4236/4885RAB9A 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.